Alici, H.; Topuz, S.; Demir, K.; Taslimi, P.; Tahtaci, H.
Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors. Pharmaceuticals 2025, 18, 962.
https://doi.org/10.3390/ph18070962
AMA Style
Alici H, Topuz S, Demir K, Taslimi P, Tahtaci H.
Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors. Pharmaceuticals. 2025; 18(7):962.
https://doi.org/10.3390/ph18070962
Chicago/Turabian Style
Alici, Hakan, Senol Topuz, Kadir Demir, Parham Taslimi, and Hakan Tahtaci.
2025. "Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors" Pharmaceuticals 18, no. 7: 962.
https://doi.org/10.3390/ph18070962
APA Style
Alici, H., Topuz, S., Demir, K., Taslimi, P., & Tahtaci, H.
(2025). Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors. Pharmaceuticals, 18(7), 962.
https://doi.org/10.3390/ph18070962